Molecular Syndromic Panel for Rapid Diagnostics of Urinary Tract Infections

Urinary tract infections (UTIs) are among the most prevalent infectious diseases, imposing a significant economic burden on healthcare systems. Traditional microbiological diagnostics for UTIs are slow, often taking several days to yield results, thus delaying the initiation of pathogen-specific antibiotic therapy. Moreover, variability in sample types, storage conditions, and patient health further complicates the interpretation of urine culture results. This webinar discusses the requirements and benefits of molecular syndromic panels for UTI diagnostics and introduces the Unyvero UTI Application, a cutting-edge solution designed to address these challenges. The panel rapidly identifies key microorganisms and their associated antibiotic resistance markers within less than 5 hours, enabling timely and appropriate treatment for UTI patients. Join us to learn how this innovative technology can enhance antibiotic stewardship and improve patient outcomes.

 

Learning Objectives